View Single Post
Old 09-29-2015, 04:24 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,975
Targeted treatment Perjeta (pertuzumab) gets regulatory green light in UK for use in

Perjeta regimen nearly doubled number of women whose tumours are eradicated versus standard treatmentOver 1,800 women per year in the UK2 with an aggressive type of breast cancer could...

More...
News is offline   Reply With Quote